MS Studies on the Metabolomics Workbench Containing Lipids

These studies were depositied in the NIH Metabolomics Data Repository from institutions around the world, and are hosted on the Metabolomics Workbench. Search, sort, and filter using the options below. Links lead to the Metabolomics Workbench website.

EI: Electron ionization(GC-MS); ESI: Electrospray ionization (LC-MS)

Search:

  Records per page  

Fields searched:
Study Title, Institute, Subject Species, MS Type (case insensitive)

Study Title
Institute
Subject Species
MS Type
Number of lipids
Pharmacometabolomic analysis of rat hippocampus and plasma in response to chronic stress and albiflorin treament (ST000903) Beijing Wonner Biotech. Ltd. Co. Rattus norvegicus ESI 105
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Colon - Untargeted HILIC-Positive (ST002664) Broad Institute of MIT and Harvard Rattus norvegicus ESI 95
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Spleen - Untargeted HILIC-Positive (ST002665) Broad Institute of MIT and Harvard Rattus norvegicus ESI 92
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Testes - Untargeted HILIC-Positive (ST002666) Broad Institute of MIT and Harvard Rattus norvegicus ESI 90
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Ovaries - Untargeted HILIC-Positive (ST002667) Broad Institute of MIT and Harvard Rattus norvegicus ESI 96
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted HILIC-Positive (ST002668) Broad Institute of MIT and Harvard Rattus norvegicus ESI 97
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted Lipidomics, Reversed-Phase Negative (ST002670) Georgia Institute of Technology Rattus norvegicus ESI 181
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted Lipidomics, Reversed-Phase Positive (ST002671) Georgia Institute of Technology Rattus norvegicus ESI 418
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted Reversed-Phase Negative (ST002672) University of Michigan Rattus norvegicus ESI 67
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Lung - Untargeted Reversed-Phase Positive (ST002673) University of Michigan Rattus norvegicus ESI 95
Mitochondrial-haplotype influences plasma metabolome, lipidome, and proteome in a sex specific manner in the genetically heterogenous OKC-HET B/W rat - Lipidomics (ST004797) Oregon State University Rattus norvegicus ESI 655
Lipidomics of Ginseng Total Secondary Saponins on Myocardial Ischemia Rat (ST001632) Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College Rattus norvegicus ESI 235
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Small Intestine - Untargeted HILIC-Positive (ST002674) Broad Institute of MIT and Harvard Rattus norvegicus ESI 95
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Liver - Untargeted HILIC-Positive (ST002675) Broad Institute of MIT and Harvard Rattus norvegicus ESI 98
Targeted mass spec-based metabolomic and clinical analyte analyses of liver and plasma samples from rats with and without hepatic knockdown of ChREBP expression. (ST003647) Duke University Rattus norvegicus EI 68
Metabolomic changes during active immunization with anti-METH vaccines. (ST000456) University of North Carolina Rattus norvegicus ESI 145
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Liver - Untargeted Lipidomics, Reversed-Phase Negative (ST002677) Georgia Institute of Technology Rattus norvegicus ESI 143
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Liver - Untargeted Lipidomics, Reversed-Phase Positive (ST002678) Georgia Institute of Technology Rattus norvegicus ESI 382
D-Allulose effects on hepatic metabolomics profile in rodents (ST001668) Matsutani Chemical Industry Co., Ltd. Rattus norvegicus ESI 102
MoTrPAC: Endurance exercise training study in young adult rats, Rat Kidney Powder - Untargeted Reversed-Phase Negative (ST002915) University of Michigan Rattus norvegicus ESI 83
Lipidomics of inflammation-induced optic nerve regeneration (ST000963) University of Miami Rattus norvegicus ESI 743
MoTrPAC: Endurance exercise training study in young adult rats, Rat Heart Powder - Untargeted Reversed-Phase Negative (ST002916) University of Michigan Rattus norvegicus ESI 83
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Liver - Untargeted Reversed-Phase Negative (ST002679) University of Michigan Rattus norvegicus ESI 66
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Liver - Untargeted Reversed-Phase Positive (ST002680) University of Michigan Rattus norvegicus ESI 100
Lipid expression in liver after early lifer exposure to an endocrine disruptor at 70 days postnatal (part-II) (ST001311) Baylor College of Medicine Rattus norvegicus ESI 131
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Brown Adipose - Untargeted HILIC-Positive (ST002682) Broad Institute of MIT and Harvard Rattus norvegicus ESI 96
Lipid expression in serum after early lifer exposure to an endocrine disruptor at 70 days postnatal (part-III) (ST001312) Baylor College of Medicine Rattus norvegicus ESI 204
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Brown Adipose - Untargeted Lipidomics, Reversed-Phase Negative (ST002684) Georgia Institute of Technology Rattus norvegicus ESI 137
MoTrPAC: Endurance exercise training study in young adult rats, Tissue:Brown Adipose - Untargeted Lipidomics, Reversed-Phase Positive (ST002685) Georgia Institute of Technology Rattus norvegicus ESI 386
Lipid expression in serum after early life exposure to an endocrine disruptor and a Western Diet at 240 days postnatal (part-IV) (ST001313) Baylor College of Medicine Rattus norvegicus ESI 204
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 (ST003036) Monash Institute of Pharmaceutical Sciences Pseudomonas aeruginosa ESI 141
Bioactive molecule(s) of gut bacteria of Crocodile (Crocodylus palustris) as potential pharmaceuticals (ST002447) Sharjah Institute for Medical Research Pseudomonas aeruginosa ESI 57
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 (ST003024) Monash Institute of Pharmaceutical Sciences Pseudomonas aeruginosa ESI 36
Metabolomic profiles in P. gingivalis treated with curcumin (ST002879) Osaka University Porphyromonas gingivalis ATCC33277 ESI 21
Metabolomic profiles in P. gingivalis cells treated with pABA (ST000384) Osaka University Porphyromonas gingivalis ATCC 33277 ESI 33
Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites (ST001205) Monash University Plasmodium falciparum;Homo sapiens ESI 234
Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites (ST001204) Monash University Plasmodium falciparum;Homo sapiens ESI 200
Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites (ST001201) Monash University Plasmodium falciparum;Homo sapiens ESI 167
Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites (ST001202) Monash University Plasmodium falciparum;Homo sapiens ESI 194
New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites (ST003160) Monash University Plasmodium falciparum ESI 171
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 (ST003179) Monash University Plasmodium falciparum ESI 297
MMV687794 blocks Plasmodium falciparum invasion of red blood cells by inhibiting a Surface-associated Lipid-Interacting Rhoptry Protein, PfSLIRP (ST004683) Monash Institute of Pharmaceutical Sciences Plasmodium falciparum ESI 688
Validating the role of the arginine to proline biosynthetic pathway in the APR (ST004233) Broad Institute of MIT and Harvard Plasmodium falciparum ESI 27
Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium (ST000546) Monash University Plasmodium falciparum ESI 145
Targeting malaria parasites with novel derivatives of azithromycin (ST002309) Monash University Plasmodium falciparum ESI 113
Retargeting azithromycin-like compounds as antimalarials with dual modality (ST001315) Monash University Plasmodium falciparum ESI 114
On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity (ST003144) Monash University Plasmodium falciparum ESI 193
Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression (ST002926) Monash University Plasmodium falciparum ESI 127
Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action (ST000414) Monash Institute of Pharmaceutical Sciences Plasmodium falciparum ESI 147
Determination of mode of action of anti-malalrial drugs using untargeted metabolomics (ST001033) Monash University Plasmodium falciparum ESI 135

Number of records: 1640

previous 50 records     next 50 records